✦ LIBER ✦

Erlotinib and Bevacizumab in Newly Diagnosed Performance Status 2 or Elderly Patients With Nonsquamous Non–Small-Cell Lung Cancer, a Phase II Study of the Hoosier Oncology Group: LUN04-77

✍ Scribed by Riggs, Heather; Jalal, Shadia I.; Baghdadi, Tareq Al; Bhatia, Sumeet; McClean, John; Johnson, Cynthia; Yu, Menggang; Taber, David; Harb, Wael; Hanna, Nasser

Book ID: 121979802
Publisher: CIG Media Group, LP.
Year: 2013
Tongue: English
Weight: 263 KB
Volume: 14
Category: Article
ISSN: 1525-7304
DOI: 10.1016/j.cllc.2012.09.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Phase II Trial of Erlotinib o

Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced Non-Small-Cell Lung Cancer and a Performance Status of 2

✍ Lilenbaum, R.; Axelrod, R.; Thomas, S.; Dowlati, A.; Seigel, L.; Albert, D.; Wit 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 205 KB

A Randomized Phase II Study of Sorafenib

A Randomized Phase II Study of Sorafenib/Gemcitabine or Sorafenib/Erlotinib for Advanced Non–Small-Cell Lung Cancer in Elderly Patients or Patients with a Performance Status of 2: Treatment Rationale and Protocol Dynamics

✍ Cesare Gridelli; Antonio Rossi; Floriana Mongillo; Maria Bareschino; Paolo Maion 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 108 KB

Randomized phase II trial of gefitinib o

Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study)

✍ Morère, Jean-François; Bréchot, Jeanne-Marie; Westeel, Virginie; Gounant, Valeri 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 483 KB

Results of a Phase II study of weekly do

Results of a Phase II study of weekly docetaxel and carboplatin in Stage IIIB (with effusion) or Stage IV non-small cell lung cancer patients age ≤65 and performance status 2

✍ Weissman, Charles H.; Sandbach, John; Brooker, Reginald; Vellek, Mark; Lindquist 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Treatment Rationale and Study Design for

Treatment Rationale and Study Design for the PointBreak Study: A Randomized, Open-label Phase III Study of Pemetrexed/Carboplatin/Bevacizumab Followed by Maintenance Pemetrexed/Bevacizumab Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer

✍ Jyoti D. Patel; Philip Bonomi; Mark A. Socinski; Ramaswamy Govindan; Shengyan Ho 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 100 KB

An open multicenter phase II trial of we

An open multicenter phase II trial of weekly docetaxel for advanced-stage non-small-cell lung cancer in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study

✍ LECAER, H; BARLESI, F; ROBINET, G; FOURNEL, P; GERINIERE, L; BOMBARON, P; FALCHE 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 179 KB